Raising hogs for a bigger goal Nov 12, 2009
She suffers from ITP, or idiopathic thrombocytopenic purpura, a blood disorder characterized by an abnormal decrease in the number of platelets in the blood. ITP affects approximately four to eight in 100,000 children under the age of 15 each year in the U.S.. (Port Lavaca Wave, TX)
Orangeburg woman receives RMC's 1st DAISY Award Jul 26, 2009
Patrick died at the age of 33 in late 1999 from complications of Idiopathic Thrombocytopenic Purpura, a little known but not uncommon auto-immune disease. The care Barnes and his family received from nurses while he was ill inspired this unique means of thanking nurses for making a profound difference in the lives of their patients and patient families. (Orangeburg Times and Democrat, SC)
New, Highly Effective Treatment For Blood Disorder Mar 27, 2009
26, 2009) Patients suffering from a blood disorder that prevents proper clotting have the option of a new medication that may dramatically improve their health. There are estimated to be between 50,000 and 100,000 individuals in the U.S. diagnosed with chronic immune thrombocytopenic purpura (ITP), an autoimmune disease that dramatically reduces the number of platelets in their blood causing bruises, nosebleeds and, rarely, life-threatening brain hemorrhages. (Science Daily)
Wakefields Shawna Kohout is DAISY award winner Mar 14, 2009
the non-profit DAISY Foundation was established in memory of J. Patrick Barnes, who died in 1999 at age 33 from complications of the autoimmune disease Idiopathic Thrombocytopenic Purpura (ITP). The DAISY Award, which stands for Diseases Attacking the Immune System, was established by Barnes wife and parents as a gesture of thanks to nurses nationwide for the profound difference they make in the lives of patients and their families. (Wakefield Daily Item, MA)
3SBio Inc. Announces Unaudited Fourth Quarter and Fiscal Year 2008 Results Mar 12, 2009
-- In December 2008, the Company filed for approval of a TPIAO label extension for the treatment of idiopathic thrombocytopenic purpura (ITP) in China, representing the first of a series of indications that the Company plans to pursue to build and grow TPIAO brand. -- 3SBio demonstrated its business development capabilities through a strategic partnership with AMAG Pharmaceutical, to develop and commercialize Ferumoxytol, a new generation of IV Iron therapy, in China. (PR Newswire)
Nplate(R) Approved in the European Union for the Treatment of Chronic Immune (Idiopathic) Thrombocytopenic Purpura (ITP) Feb 7, 2009
(PRNewsFoto/Amgen) THOUSAND OAKS, CA UNITED STATES. First and Only Approved Platelet Producer in Europe Represents New Treatment Approach for Serious Chronic Autoimmune Disorder. (PR Newswire)
